Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. The Cooper's annualized net income for the quarter that ended in Jan. 2025 was $417 Mil. The Cooper's average shareholder tangible equity for the quarter that ended in Jan. 2025 was $2,525 Mil. Therefore, The Cooper's annualized Return-on-Tangible-Equity for the quarter that ended in Jan. 2025 was 16.52%.
The historical rank and industry rank for The Cooper's Return-on-Tangible-Equity or its related term are showing as below:
COO'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 15.1 Med: 100.2 Max: 366.83
Current: 17.71
During the past 13 years, The Cooper's highest Return-on-Tangible-Equity was 366.83%. The lowest was 15.10%. And the median was 100.20%.
COO's Return-on-Tangible-Equity is ranked better than 81.35% of 756
companies
in the Medical Devices & Instruments industry
Industry Median: 2.6
vs COO: 17.71
The Cooper Return-on-Tangible-Equity Historical Data
The historical data trend for The Cooper's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of The Cooper's Return-on-Tangible-Equity
For the Medical Instruments & Supplies subindustry, The Cooper's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Cooper's Return-on-Tangible-Equity Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, The Cooper's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where The Cooper's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Jan. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
The Cooper (NAS:COO) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
The Cooper Return-on-Tangible-Equity Related Terms
Thank you for viewing the detailed overview of The Cooper's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.
CooperCompanies is one of the largest eyecare companies in the us. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the us contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the us, and controls 17% of the us IUD market.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
COO has been successfully added to your 